Rive Sarfstein

1.9k total citations
51 papers, 1.5k citations indexed

About

Rive Sarfstein is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Rive Sarfstein has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Rive Sarfstein's work include Growth Hormone and Insulin-like Growth Factors (36 papers), Metabolism, Diabetes, and Cancer (26 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Rive Sarfstein is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (36 papers), Metabolism, Diabetes, and Cancer (26 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Rive Sarfstein collaborates with scholars based in Israel, United States and Italy. Rive Sarfstein's co-authors include Haim Werner, Ilan Bruchim, Zvi Laron, Charles L. Jaffe, Ami Fishman, Sharon Maor, Karthik Nagaraj, Edgar Pick, Metsada Pasmanik‐Chor and Yara Gorzalczany and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Rive Sarfstein

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rive Sarfstein Israel 26 899 471 388 244 202 51 1.5k
Larbi Amazit France 25 1.2k 1.3× 406 0.9× 217 0.6× 349 1.4× 128 0.6× 40 2.0k
Mark Collinge United States 20 749 0.8× 295 0.6× 218 0.6× 271 1.1× 419 2.1× 37 1.8k
Noël Lamandé France 21 865 1.0× 167 0.4× 296 0.8× 124 0.5× 133 0.7× 38 1.6k
Stefan Schmidt Austria 18 718 0.8× 132 0.3× 223 0.6× 257 1.1× 260 1.3× 40 1.4k
Tsuyoshi Kadomatsu Japan 26 809 0.9× 239 0.5× 704 1.8× 175 0.7× 211 1.0× 60 2.1k
Johan Lidén Sweden 14 415 0.5× 213 0.5× 336 0.9× 264 1.1× 327 1.6× 18 1.2k
I. Viard Switzerland 17 744 0.8× 236 0.5× 146 0.4× 293 1.2× 467 2.3× 22 2.2k
Sandra Cascio United States 21 917 1.0× 128 0.3× 487 1.3× 405 1.7× 216 1.1× 41 1.7k
Zhi‐Ming Ding United States 19 700 0.8× 703 1.5× 220 0.6× 139 0.6× 335 1.7× 47 1.9k
Christer Ericsson Sweden 18 600 0.7× 234 0.5× 233 0.6× 141 0.6× 180 0.9× 40 1.3k

Countries citing papers authored by Rive Sarfstein

Since Specialization
Citations

This map shows the geographic impact of Rive Sarfstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rive Sarfstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rive Sarfstein more than expected).

Fields of papers citing papers by Rive Sarfstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rive Sarfstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rive Sarfstein. The network helps show where Rive Sarfstein may publish in the future.

Co-authorship network of co-authors of Rive Sarfstein

This figure shows the co-authorship network connecting the top 25 collaborators of Rive Sarfstein. A scholar is included among the top collaborators of Rive Sarfstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rive Sarfstein. Rive Sarfstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werner, Haim, Rive Sarfstein, & Zvi Laron. (2021). The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer. Biomolecules. 11(4). 531–531. 29 indexed citations
2.
Sarfstein, Rive, Manisha Dixit, Shoshana Yakar, et al.. (2021). ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease. Frontiers in Endocrinology. 12. 688104–688104. 4 indexed citations
3.
Sarfstein, Rive, et al.. (2020). Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns. Frontiers in Endocrinology. 11. 435–435. 2 indexed citations
4.
Werner, Haim, Rive Sarfstein, & Ilan Bruchim. (2019). Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy. Expert Opinion on Investigational Drugs. 28(12). 1101–1112. 48 indexed citations
5.
Nagaraj, Karthik, Rive Sarfstein, David Gurwitz, et al.. (2018). Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action. Proceedings of the National Academy of Sciences. 115(5). 1045–1050. 49 indexed citations
6.
Pasmanik‐Chor, Metsada, et al.. (2016). Identification of signaling pathways associated with cancer protection in Laron syndrome. Endocrine Related Cancer. 23(5). 399–410. 31 indexed citations
7.
Sarfstein, Rive, et al.. (2015). Proliferative and signaling activities of insulin analogues in endometrial cancer cells. Molecular and Cellular Endocrinology. 406. 27–39. 11 indexed citations
8.
Bruchim, Ilan, Rive Sarfstein, Ari Reiss, Eliezer Flescher, & Haim Werner. (2014). IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer. Cancer Letters. 352(2). 214–219. 5 indexed citations
9.
Bruchim, Ilan, Rive Sarfstein, & Haim Werner. (2014). The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches. Frontiers in Endocrinology. 5. 76–76. 68 indexed citations
10.
Sarfstein, Rive, Metsada Pasmanik‐Chor, Adva Yeheskel, et al.. (2011). Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells. Journal of Biological Chemistry. 287(4). 2766–2776. 76 indexed citations
11.
Bentov, Itay, Dvora Kidron, Rive Sarfstein, et al.. (2011). p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy. European Journal of Cancer. 48(10). 1570–1580. 35 indexed citations
12.
Sarfstein, Rive, Ilan Bruchim, Ami Fishman, & Haim Werner. (2011). The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway. PLoS ONE. 6(9). e24468–e24468. 32 indexed citations
13.
Aiello, Aurora, Giuseppe Pandini, Rive Sarfstein, et al.. (2010). HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene. European Journal of Cancer. 46(10). 1919–1926. 29 indexed citations
14.
Ravid, Dana, et al.. (2006). Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Experimental Cell Research. 312(19). 3899–3908. 26 indexed citations
15.
Maor, Sharon, Doris Mayer, Ronit I. Yarden, et al.. (2006). Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Journal of Endocrinology. 191(3). 605–612. 90 indexed citations
16.
Sarfstein, Rive, Yara Gorzalczany, Ariel Mizrahi, et al.. (2004). Dual Role of Rac in the Assembly of NADPH Oxidase, Tethering to the Membrane and Activation of p67. Journal of Biological Chemistry. 279(16). 16007–16016. 114 indexed citations
17.
Sigal, Natalia, Yara Gorzalczany, Rive Sarfstein, et al.. (2003). The Guanine Nucleotide Exchange Factor Trio Activates the Phagocyte NADPH Oxidase in the Absence of GDP to GTP Exchange on Rac. Journal of Biological Chemistry. 278(7). 4854–4861. 26 indexed citations
18.
Schnur, L. F., Rive Sarfstein, & Charles L. Jaffe. (1990). Monoclonal antibodies against leishmanial membranes react with specific excreted factors (EF). Annals of Tropical Medicine and Parasitology. 84(5). 447–456. 14 indexed citations
19.
Jaffe, Charles L., et al.. (1990). Leishmania tropica: Characterization of a lipophosphoglycan-like antigen recognized by species-specific monoclonal antibodies. Experimental Parasitology. 70(1). 12–24. 11 indexed citations
20.
Jaffe, Charles L., Nurit Rachamim, & Rive Sarfstein. (1990). Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.. The Journal of Immunology. 144(2). 699–706. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larbi Amazit Breakdown of academic impact, for papers by Mark Collinge Breakdown of academic impact, for papers by Noël Lamandé Breakdown of academic impact, for papers by Stefan Schmidt Breakdown of academic impact, for papers by Tsuyoshi Kadomatsu Breakdown of academic impact, for papers by Johan Lidén Breakdown of academic impact, for papers by I. Viard Breakdown of academic impact, for papers by Sandra Cascio Breakdown of academic impact, for papers by Zhi‐Ming Ding Breakdown of academic impact, for papers by Christer Ericsson
Rankless by CCL
2026